CAS NO: | 200619-13-2 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | DRF-1042 is an orally active derivative of Camptothecin. DRF-1042 acts to inhibitDNAtopoisomeraseI. DRF-1042 shows good anticancer activity against a panel of humancancercell lines including multi-drug resistance (MDR) phenotype[1][2]. | ||||||||||||||||
IC50& Target | DNA topoisomerase I[1] | ||||||||||||||||
体外研究 (In Vitro) | DRF-1042 demonstrates superior lactone stability and good in vitro anticancer activity against a panel of human cancer cell lines including multi-drug resistance (MDR) phenotype[2]. | ||||||||||||||||
体内研究 (In Vivo) | In clonogenic assay against murine, canine and human bone marrow cells, DRF-1042 treatment shows less mylosupression that supports the possibility of protracted dose schedule in both experimental and clinical studies[2]. | ||||||||||||||||
分子量 | 408.40 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C22H20N2O6 | ||||||||||||||||
CAS 号 | 200619-13-2 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | -20°C, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 50 mg/mL(122.43 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|